Previous findings have demonstrated that heterofusion of breast cancer cells with endothelial cells involves endothelial cell associated ASCT2 (alanine, serine, and cysteine selective transporter-2) which functions as a syncytin receptor present on breast cancer cells [24]. This evidence concerns the gene SLC1A5 and breast carcinoma.